Detect cancer when it matters
the most—Because everyone
deserves a fighting chance.
The key to managing cancer is early detection. ClearNote Health makes this possible by finding signals of cancer in your blood early, when treatment is the most effective.
Our Approach
ClearNote Health’s proprietary epigenomic platform and cell-free DNA-based assays measure dynamic biological changes in cells to provide an early signal of a developing cancer.
Our Tests
ClearNote Health focuses on cancers with high mortality rates for which there are no or very limited detection options.
Recent News
We are proud of the clinical evidence, R&D achievements, and our five-year-long company development as Bluestar Genomics. Now, as a commercial-stage company, ClearNote Health continues to drive innovation in non-invasive cancer detection, with patient needs at the core of everything we pursue.
